These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

392 related items for PubMed ID: 17187388

  • 1. First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage.
    Bérard A, Ramos E, Rey E, Blais L, St-André M, Oraichi D.
    Birth Defects Res B Dev Reprod Toxicol; 2007 Feb; 80(1):18-27. PubMed ID: 17187388
    [Abstract] [Full Text] [Related]

  • 2. SSRI antidepressants and birth defects.
    Prescrire Int; 2006 Dec; 15(86):222-3. PubMed ID: 17167929
    [Abstract] [Full Text] [Related]

  • 3. Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors.
    Bar-Oz B, Einarson T, Einarson A, Boskovic R, O'Brien L, Malm H, Bérard A, Koren G.
    Clin Ther; 2007 May; 29(5):918-926. PubMed ID: 17697910
    [Abstract] [Full Text] [Related]

  • 4. The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis.
    Bérard A, Iessa N, Chaabane S, Muanda FT, Boukhris T, Zhao JP.
    Br J Clin Pharmacol; 2016 Apr; 81(4):589-604. PubMed ID: 26613360
    [Abstract] [Full Text] [Related]

  • 5. Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study.
    Diav-Citrin O, Shechtman S, Weinbaum D, Wajnberg R, Avgil M, Di Gianantonio E, Clementi M, Weber-Schoendorfer C, Schaefer C, Ornoy A.
    Br J Clin Pharmacol; 2008 Nov; 66(5):695-705. PubMed ID: 18754846
    [Abstract] [Full Text] [Related]

  • 6. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S, Nourrisson A, Jaafari N, Pérault Pochat MC.
    Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [Abstract] [Full Text] [Related]

  • 7. Antidepressant use in pregnancy and the risk of cardiac defects.
    Huybrechts KF, Palmsten K, Avorn J, Cohen LS, Holmes LB, Franklin JM, Mogun H, Levin R, Kowal M, Setoguchi S, Hernández-Díaz S.
    N Engl J Med; 2014 Jun 19; 370(25):2397-407. PubMed ID: 24941178
    [Abstract] [Full Text] [Related]

  • 8. Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of fetal major malformations: focus on paroxetine.
    Gentile S, Bellantuono C.
    J Clin Psychiatry; 2009 Mar 19; 70(3):414-22. PubMed ID: 19254517
    [Abstract] [Full Text] [Related]

  • 9. Paroxetine use during pregnancy and perinatal outcomes including types of cardiac malformations in Quebec and France: a short communication.
    Bérard A, Sheehy O, Damase-Michel C, Crespin S.
    Curr Drug Saf; 2012 Jul 19; 7(3):207-10. PubMed ID: 22950376
    [Abstract] [Full Text] [Related]

  • 10. Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort.
    Bérard A, Zhao JP, Sheehy O.
    BMJ Open; 2017 Jan 12; 7(1):e013372. PubMed ID: 28082367
    [Abstract] [Full Text] [Related]

  • 11. First-trimester use of paroxetine and congenital heart defects: a population-based case-control study.
    Bakker MK, Kerstjens-Frederikse WS, Buys CH, de Walle HE, de Jong-van den Berg LT.
    Birth Defects Res A Clin Mol Teratol; 2010 Feb 12; 88(2):94-100. PubMed ID: 19937603
    [Abstract] [Full Text] [Related]

  • 12. Sertraline use during pregnancy and the risk of major malformations.
    Bérard A, Zhao JP, Sheehy O.
    Am J Obstet Gynecol; 2015 Jun 12; 212(6):795.e1-795.e12. PubMed ID: 25637841
    [Abstract] [Full Text] [Related]

  • 13. Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births.
    Gao SY, Wu QJ, Sun C, Zhang TN, Shen ZQ, Liu CX, Gong TT, Xu X, Ji C, Huang DH, Chang Q, Zhao YH.
    BMC Med; 2018 Nov 12; 16(1):205. PubMed ID: 30415641
    [Abstract] [Full Text] [Related]

  • 14. Duration of antidepressant use during pregnancy and risk of major congenital malformations.
    Ramos E, St-André M, Rey E, Oraichi D, Bérard A.
    Br J Psychiatry; 2008 May 12; 192(5):344-50. PubMed ID: 18450657
    [Abstract] [Full Text] [Related]

  • 15. Use of selective serotonin reuptake inhibitors in pregnancy and cardiac malformations: a propensity-score matched cohort in CPRD.
    Margulis AV, Abou-Ali A, Strazzeri MM, Ding Y, Kuyateh F, Frimpong EY, Levenson MS, Hammad TA.
    Pharmacoepidemiol Drug Saf; 2013 Sep 12; 22(9):942-51. PubMed ID: 23733623
    [Abstract] [Full Text] [Related]

  • 16. Paroxetine in the first trimester and the prevalence of congenital malformations.
    Cole JA, Ephross SA, Cosmatos IS, Walker AM.
    Pharmacoepidemiol Drug Saf; 2007 Oct 12; 16(10):1075-85. PubMed ID: 17729379
    [Abstract] [Full Text] [Related]

  • 17. Paroxetine use in pregnancy and increased risk of heart defects: Evaluating the evidence.
    Einarson A.
    Can Fam Physician; 2010 Aug 12; 56(8):767-8. PubMed ID: 20705881
    [Abstract] [Full Text] [Related]

  • 18. Does paroxetine cause cardiac malformations?
    O'Brien L, Einarson TR, Sarkar M, Einarson A, Koren G.
    J Obstet Gynaecol Can; 2008 Aug 12; 30(8):696-701. PubMed ID: 18786292
    [Abstract] [Full Text] [Related]

  • 19. Paroxetine may increase risk for congenital malformations.
    Cuzzell JZ.
    Dermatol Nurs; 2006 Feb 12; 18(1):68. PubMed ID: 16617525
    [No Abstract] [Full Text] [Related]

  • 20. Paroxetine exposure during pregnancy and cardiac malformations.
    Scialli AR.
    Birth Defects Res A Clin Mol Teratol; 2010 Mar 12; 88(3):175-7. PubMed ID: 20175190
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.